PUBLISHER: The Business Research Company | PRODUCT CODE: 1763055
PUBLISHER: The Business Research Company | PRODUCT CODE: 1763055
Arcalyst (rilonacept) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Arcalyst (rilonacept) is a prescription medication classified as an interleukin-1 (IL-1) blocker. It is used to treat inflammatory conditions caused by the overproduction of interleukin-1, a protein that plays a key role in the body's inflammatory response. Rilonacept works by binding to interleukin-1 alpha and beta, preventing their interaction with specific receptors, thus reducing inflammation and alleviating symptoms related to these conditions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary formulations of arcalyst (rilonacept) include lyophilized and liquid forms. The lyophilized version is a freeze-dried formulation designed for reconstitution prior to administration. Arcalyst is indicated for conditions such as cryopyrin-associated periodic syndromes (CAPS), deficiency of interleukin-1 receptor antagonist (DIRA), and other indications. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and is used by both adult and pediatric patients.
The arcalyst (rilonacept) market research report is one of a series of new reports from The Business Research Company that provides arcalyst (rilonacept) market statistics, including arcalyst (rilonacept) industry global market size, regional shares, competitors with a arcalyst (rilonacept) market share, detailed arcalyst (rilonacept) market segments, market trends and opportunities, and any further data you may need to thrive in the arcalyst (rilonacept) industry. This arcalyst (rilonacept) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The arcalyst (rilonacept) market size is expected to see strong growth in the next few years. It will grow to $311.7 million in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to growing demand for injectable biologics, rise in healthcare expenditure, increasing global patient population, rising demand for treatments for inflammatory diseases, rise in demand for personalized medicine. Major trends in the forecast period include advancements in biologic therapies for autoimmune conditions, collaborations between pharmaceutical companies, advances in precision medicine and targeted therapies, technological advancements, innovations in drug delivery systems.
The growing demand for personalized medicines is expected to drive the growth of the arcalyst (rilonacept) market going forward. Personalized medicine tailors treatment and healthcare decisions to an individual's characteristics, including genetics, environment, and lifestyle. The demand for personalized medicine is rising due to its potential to improve treatment effectiveness, reduce adverse effects, and address individual variability in disease progression and drug response. As personalized medicine becomes more common, there is greater awareness and better diagnostic tools to identify rare, genetically driven conditions, which results in an increase in diagnoses that Arcalyst can treat. For instance, in February 2024, the Personalized Medicine Coalition (PMC) reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to just 6 in 2022. Additionally, in February 2023, PMC reported that 12 new personalized medicines were approved by the FDA in 2022, marking the eighth consecutive year where personalized medicines comprised at least a quarter of all new drug approvals. Therefore, the growing demand for personalized medicines is driving the growth of the arcalyst (rilonacept) market.
A key trend in the arcalyst (rilonacept) market is adopting a strategic partnership approach to develop and commercialize Arcalyst with enhanced technology integration and to expand market reach. Strategic partnerships enable companies to leverage each other's strengths and resources to achieve mutual success. For instance, in February 2022, Kiniksa Pharmaceuticals Ltd., a Bermuda-based biopharmaceutical company, partnered with Huadong Medicine Co. Ltd., a China-based pharmaceutical company, to develop and commercialize Arcalyst and mavrilimumab in the Asia-Pacific region. Under this agreement, Kiniksa received an upfront payment of $22 million and could earn up to $640 million through milestone payments based on development, regulatory approvals, and sales. Huadong Medicine holds exclusive rights for the development and commercialization of Arcalyst in Greater China, South Korea, Australia, and 18 other countries, excluding Japan.
In August 2023, Fairmount Funds Management LLC, a South Philadelphia-based investment firm, acquired a stake in Kiniksa Pharmaceuticals for an undisclosed amount. This strategic move is part of Fairmount's broader investment strategy aimed at long-term value generation within the biotechnology sector. Kiniksa Pharmaceuticals is the manufacturer of Arcalyst (rilonacept).
Major players operating in the arcalyst (rilonacept) market are Regeneron Pharmaceuticals Inc., Kiniksa Pharmaceuticals Ltd.
North America was the largest region in the arcalyst (rilonacept) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arcalyst (rilonacept) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the arcalyst (rilonacept) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The arcalyst (rilonacept) market consists of monoclonal antibodies, anti-inflammatory drugs, rare disease drugs and other related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Arcalyst (rilonacept) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on arcalyst (rilonacept) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for arcalyst (rilonacept) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arcalyst (rilonacept) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Lyophilized; Liquid
- 2) By Indication: Cryopyrin-Associated Periodic Syndromes (CAPS); Deficiency Of Interleukin-1 Receptor Antagonist (DIRA); Other Indications
- 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 4) By End User: Adult Patients; Pediatric Patients
- Companies Mentioned: Regeneron Pharmaceuticals Inc.; Kiniksa Pharmaceuticals Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Arcalyst (Rilonacept) Market Characteristics
3. Arcalyst (Rilonacept) Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route Of Administration (ROA)
- 3.3. Mechanism Of Action (MOA)
- 3.4. Safety And Efficacy
4. Arcalyst (Rilonacept) Market Trends And Strategies
5. Arcalyst (Rilonacept) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Arcalyst (Rilonacept) Growth Analysis And Strategic Analysis Framework
- 6.1. Global Arcalyst (Rilonacept) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis Of End Use Industries
- 6.3. Global Arcalyst (Rilonacept) Market Growth Rate Analysis
- 6.4. Global Arcalyst (Rilonacept) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 6.5. Global Arcalyst (Rilonacept) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 6.6. Global Arcalyst (Rilonacept) Total Addressable Market (TAM)
7. Global Arcalyst (Rilonacept) Market Pricing Analysis & Forecasts
8. Arcalyst (Rilonacept) Market Segmentation
- 8.1. Global Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lyophilized
- Liquid
- 8.2. Global Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cryopyrin-Associated Periodic Syndromes (CAPS)
- Deficiency Of Interleukin-1 Receptor Antagonist (DIRA)
- Other Indications
- 8.3. Global Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 8.4. Global Arcalyst (Rilonacept) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adult Patients
- Pediatric Patients
9. Global Arcalyst (Rilonacept) Market Epidemiology Of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence And Prevalence of Clinical Indications
10. Arcalyst (Rilonacept) Market Regional And Country Analysis
- 10.1. Global Arcalyst (Rilonacept) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. Global Arcalyst (Rilonacept) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Arcalyst (Rilonacept) Market
- 11.1. Asia-Pacific Arcalyst (Rilonacept) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Asia-Pacific Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Asia-Pacific Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Arcalyst (Rilonacept) Market
- 12.1. China Arcalyst (Rilonacept) Market Overview
- 12.2. China Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.3. China Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.4. China Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Arcalyst (Rilonacept) Market
- 13.1. India Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. India Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. India Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Arcalyst (Rilonacept) Market
- 14.1. Japan Arcalyst (Rilonacept) Market Overview
- 14.2. Japan Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. Japan Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. Japan Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Arcalyst (Rilonacept) Market
- 15.1. Australia Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.2. Australia Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Australia Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Arcalyst (Rilonacept) Market
- 16.1. South Korea Arcalyst (Rilonacept) Market Overview
- 16.2. South Korea Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. South Korea Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.4. South Korea Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Arcalyst (Rilonacept) Market
- 17.1. Western Europe Arcalyst (Rilonacept) Market Overview
- 17.2. Western Europe Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Western Europe Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.4. Western Europe Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Arcalyst (Rilonacept) Market
- 18.1. UK Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. UK Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. UK Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Arcalyst (Rilonacept) Market
- 19.1. Germany Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Germany Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Germany Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Arcalyst (Rilonacept) Market
- 20.1. France Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. France Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. France Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Arcalyst (Rilonacept) Market
- 21.1. Eastern Europe Arcalyst (Rilonacept) Market Overview
- 21.2. Eastern Europe Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Arcalyst (Rilonacept) Market
- 22.1. North America Arcalyst (Rilonacept) Market Overview
- 22.2. North America Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. North America Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.4. North America Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Arcalyst (Rilonacept) Market
- 23.1. USA Arcalyst (Rilonacept) Market Overview
- 23.2. USA Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. USA Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. USA Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Arcalyst (Rilonacept) Market
- 24.1. Canada Arcalyst (Rilonacept) Market Overview
- 24.2. Canada Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. Canada Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. Canada Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Arcalyst (Rilonacept) Market
- 25.1. South America Arcalyst (Rilonacept) Market Overview
- 25.2. South America Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. South America Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. South America Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Arcalyst (Rilonacept) Market
- 26.1. Middle East Arcalyst (Rilonacept) Market Overview
- 26.2. Middle East Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. Middle East Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. Middle East Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Arcalyst (Rilonacept) Market
- 27.1. Africa Arcalyst (Rilonacept) Market Overview
- 27.2. Africa Arcalyst (Rilonacept) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Africa Arcalyst (Rilonacept) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.4. Africa Arcalyst (Rilonacept) Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Arcalyst (Rilonacept) Market Competitive Landscape And Company Profiles
- 28.1. Arcalyst (Rilonacept) Market Competitive Landscape
- 28.2. Arcalyst (Rilonacept) Market Company Profiles
- 28.2.1. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 28.2.2. Kiniksa Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
29. Global Arcalyst (Rilonacept) Market Pipeline Analysis
- 29.1. High Level Clinic Trail Information
30. Global Arcalyst (Rilonacept) Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Arcalyst (Rilonacept) Market
32. Recent Developments In The Arcalyst (Rilonacept) Market
33. Arcalyst (Rilonacept) Market High Potential Countries, Segments and Strategies
- 33.1 Arcalyst (Rilonacept) Market In 2029 - Countries Offering Most New Opportunities
- 33.2 Arcalyst (Rilonacept) Market In 2029 - Segments Offering Most New Opportunities
- 33.3 Arcalyst (Rilonacept) Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies
34. Appendix
- 34.1. Abbreviations
- 34.2. Currencies
- 34.3. Historic And Forecast Inflation Rates
- 34.4. Research Inquiries
- 34.5. The Business Research Company
- 34.6. Copyright And Disclaimer
